Formulation of nanosuspensions of gymnemic acids for oral administration
by R. Ravichandran
International Journal of Nanoparticles (IJNP), Vol. 3, No. 4, 2010

Abstract: Integration of ayurveda and pharmaceutical technological advances are being used to make effective drug delivery system of gymnemic acids. In recent years, there has been a considerable interest in the development of novel drug delivery systems using nanotechnology. In the present work an attempt has been made to prepare and formulate gymnemic acids nanocrystal in order to improve the dissolution velocity and enhance the bioavailability. The gymnemic acids nanosuspension prepared was dried by lyophilisation and characterised for its physico-chemical properties and the re-dispersion of it in water was intensively investigated. Morphology of the particles was also analysed. Finally, gymnemic acids nanocrystal-loaded tablets were developed using direct compression and its dissolution behaviour was evaluated in various dispersion media. The improved dissolution behaviour of the gymnemic acids nanocrystal-loaded tablet should lead to a better bioavailability of the poorly soluble gymnemic acids in the body.

Online publication date: Fri, 26-Nov-2010

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Nanoparticles (IJNP):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com